⌘K

Login Start Free

Home/Filings/4/0001104659-22-127971

4//SEC Filing

Tufaro Francis 4

Accession 0001104659-22-127971

CIK 0000894158other

View on SEC.gov Company Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 6:16 PM ET

Size

5.7 KB

Accession

0001104659-22-127971

Insider Transaction Report

Form 4

Period: 2022-12-15

Theriva Biologics, Inc.TOVX

Chief Operating Officer

Transactions

Award
Stock Options (right to buy)
2022-12-15+100,000→ 100,000 total
Exercise: $0.58From: 2023-01-15Exp: 2029-12-15→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]These stock options vest pro rata on a monthly basis over 36 months.

Documents

1 file

4
tm2232925-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Theriva Biologics, Inc.

CIK 0000894158

Entity typeother

Related Parties

1

filerCIK 0001906510

Filing Metadata

Form type: 4
Filed: Dec 15, 7:00 PM ET
Accepted: Dec 16, 6:16 PM ET
Size: 5.7 KB

View on SEC.gov